Prognosis Comparison of Use of Oral Anticoagulants and Vitamin K Antagonists in Patients with Intracerebral Hemorrhage

Authors

I Made Arya Yogiswara Mahayasa , Puspasari Mahadewi , Luthfiyah Kamila , Ayu Santia Dewi , Muhammad Faeyza , Baiq Wanda Annisa , Arif Setyo , Shania Hafista , Bagas Ekasangga , Adinda Citra , Ulfa Ramdhani , Yusuf Alfian , Arfi Syamsun

DOI:

10.29303/jbt.v22i4.4176

Published:

2022-12-09

Downloads

Abstract

This study reviewed the literature on the incidence of Intracerebral Hemorrhage (ICH) associated with the use of oral anticoagulant drugs (OAC) and vitamin K antagonists (VKA), then compared the outcomes of using these drugs in terms of mortality, morbidity or prognosis in patients. We did a search on online databases including Pubmed, Google Scholar and Science Direct according to the specified keywords. The results obtained amounted to 935 articles. From these articles, the types of research that met the inclusion and exclusion criteria were then re-screened and the final search results were obtained as many as 10 articles. The results of this study found that of the 10 articles reviewed, 8 of them showed p value > 0.05 so that there was no significant difference between the outcomes of ICH related to OAC or VKA, where outcomes were viewed from the factors of bleeding widening, ICH volume, mortality, and functional impact. Meanwhile, from 2 articles that showed significant results, it was stated that the prognosis of the incidence of ICH related to the use of OAC was better than the use of VKA. Research on ICH, research on original article types, according to predetermined keywords, is a publication in the period 2012-2022, human studies and articles can be accessed.

Keywords:

intracerebral hemorrhage oral anticoagulant vitamin K antagonist outcome prognosis

References

An SJ, Kim TJ, & Yoon BW (2017). Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: An update. Journal of Stroke. Korean Stroke Society; 19. p. 3–10.

Apostolaki-Hansson T, Ullberg T, Norrving B, Petersson J. (2019). Prognosis for intracerebral hemorrhage during ongoing oral anticoagulant treatment. Acta Neurol Scand, 139(5):415–21.

Brekelmans MPA, Abdoellakhan RA, Scheres LJJ, Biedermann JS, Hutten BA, Meijer K, Cate H ten, Huisman M v., Kruip MJHA, Middeldorp S, … . & Coppens M. (2018). Clinical outcome of patients with a vitamin K antagonist-associated bleeding treated with prothrombin complex concentrate. Res Pract Thromb Haemost, 2(1):77–84.

Chen SJ, Yeh SJ, Tang SC, Lin SY, Tsai LK, Jeng JS. (2020). Similar outcomes between vitamin K and non-vitamin K antagonist oral anticoagulants associated intracerebral hemorrhage. Journal of the Formosan Medical Association, 119(1P1):106–12.

Franco L, Paciaroni M, Enrico ML, Scoditti U, Guideri F, Chiti A, de Vito A, Terruso V, Consoli D, Vanni S, Giossi A, Manina G, Nitti C, Re R, Sacco S, Cappelli R, Beyer-Westendorf J, Pomero F, Agnelli G, … . & Becattini C. (2020). Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy. Eur J Intern Med, 75:35–43.

Gerner ST, Kuramatsu JB, Sembill JA, Sprügel MI, Hagen M, Knappe RU, Endres M, Haeusler KG, Sobesky J, Schurig J, Zweynert S, Bauer M, Vajkoczy P, Ringleb PA, Purrucker JC, Rizos T, Volkmann J, Müllges W, Kraft P, Schubert AL, Erbguth F, Nueckel M, Schellinger PD, Glahn J, Knappe UJ, Fink GR, Dohmen C, Stetefeld H, Fisse AL, Minnerup J, Hagemann G, Rakers F, Reichmann H, Schneider H, Rahmig J, Ludolph AC, Stösser S, Neugebauer H, Röther J, Michels P, Schwarz M, Reimann G, Bäzner H, Schwert H, Claßen J, Michalski D, Grau A, Palm F, Urbanek C, Wöhrle JC, Alshammari F, Horn M, Bahner D, Witte OW, Günther A, Hamann GF, Engelhorn T, Lücking H, Dörfler A, Schwab S, … . & Huttner HB. (2019). Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage. Stroke, 50(6):1392–402.

Kawabori M, Niiya Y, Iwasaki M, Mabuchi S, Ozaki H, Matsubara K, Houkin K. (2018). Characteristics of Symptomatic Intracerebral Hemorrhage in Patient Receiving Direct Oral Anticoagulants: Comparison with Warfarin. Journal of Stroke and Cerebrovascular Diseases, 27(5):1338–42.

Marques-Matos C, Alves JN, Marto JP, Ribeiro JA, Monteiro A, Araújo J, Silva F, Grenho F, Viana-Baptista M, Sargento-Freitas J, Pinho J, … . & Azevedo E. (2017). POST-NOAC: Portuguese observational study of intracranial hemorrhage on non-vitamin K antagonist oral anticoagulants. International Journal of Stroke, 12(6):623–627.

Melmed KR, Lyden P, Gellada N, & Moheet A. (2017). Intracerebral Hemorrhagic Expansion Occurs in Patients Using Non–Vitamin K Antagonist Oral Anticoagulants Comparable with Patients Using Warfarin. Journal of Stroke and Cerebrovascular Diseases, 26(8):1874–82.

Miller MM, Lowe J, Khan M, Azeem MU, Muehlschlegel S, Jun-O’Connell AH, Goddeau RP, Moonis M, Gritters D, Silver B, … . & Henninger N. (2019). Clinical and Radiological Characteristics of Vitamin K versus Non-Vitamin K Antagonist Oral Anticoagulation-Related Intracerebral Hemorrhage. Neurocrit Care, 31(1):56–65.

Rajashekar D, & Liang JW. (2022). Intracerebral Hemorrhage. StatPearls [Internet]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK553103/

Tsivgoulis G, Lioutas VA, Varelas P, Katsanos AH, Goyal N, Mikulik R, Barlinn K, Krogias C, Sharma VK, Vadikolias K, Dardiotis E, Karapanayiotides T, Pappa A, Zompola C, Triantafyllou S, Kargiotis O, Ioakeimidis M, Giannopoulos S, Kerro A, Tsantes A, Mehta C, Jones M, Schroeder C, Norton C, Bonakis A, Chang J, Alexandrov AW, Mitsias P, … . & Alexandrov A v. (2017). Direct oral anticoagulant-vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage. Neurology, vol 89.

Tsivgoulis G, Lioutas VA, Varelas P, Katsanos AH, Goyal N, Mikulik R, Barlinn K, Krogias C, Sharma VK, Vadikolias K, Dardiotis E, Karapanayiotides T, Pappa A, Zompola C, Triantafyllou S, Kargiotis O, Ioakeimidis M, Giannopoulos S, Kerro A, Tsantes A, Mehta C, Jones M, Schroeder C, Norton C, Bonakis A, Chang J, Alexandrov AW, Mitsias P, … . & Alexandrov A v. (2017). Direct oral anticoagulant-vs Vitamin K antagonist-related nontraumatic intracerebral hemorrhage. Neurology, 89(11):1142–51.

Wilson D, Seiffge DJ, Traenka C, Basir G, Purrucker JC, Rizos T, Sobowale OA, Sallinen H, Yeh SJ, Wu TY, Ferrigno M, Houben R, Schreuder FHBM, Perry LA, Tanaka J, Boulanger M, Salman RAS, Jäger HR, Ambler G, Shakeshaft C, Yakushiji Y, Choi PMC, Staals J, Cordonnier C, Jeng JS, Veltkamp R, Dowlatshahi D, Engelter ST, Parry-Jones AR, Meretoja A, Werring DJ. (2017). Outcome of intracerebral hemorrhage associated with different oral anticoagulants. Neurology, 88(18):1693–700.

Author Biographies

I Made Arya Yogiswara Mahayasa, Universitas Mataram

Author Origin : Indonesia

Puspasari Mahadewi, Universitas Mataram

Author Origin : Indonesia

Luthfiyah Kamila, Universitas Mataram

Author Origin : Indonesia

Ayu Santia Dewi, Universitas Mataram

Author Origin : Indonesia

Muhammad Faeyza, Universitas Mataram

Author Origin : Indonesia

Baiq Wanda Annisa, Universitas Mataram

Author Origin : Indonesia

Arif Setyo, Universitas Mataram

Author Origin : Indonesia

Shania Hafista, Universitas Mataram

Author Origin : Indonesia

Bagas Ekasangga, Universitas Mataram

Author Origin : Indonesia

Adinda Citra, Universitas Mataram

Author Origin : Indonesia

Ulfa Ramdhani, Universitas Mataram

Author Origin : Indonesia

Yusuf Alfian, Universitas Mataram

Author Origin : Indonesia

Arfi Syamsun, Universitas Mataram

Author Origin : Indonesia

Downloads

Download data is not yet available.

How to Cite

Mahayasa, I. M. A. Y., Mahadewi, P., Kamila, L., Dewi, A. S., Faeyza, M., Annisa, B. W., … Syamsun, A. (2022). Prognosis Comparison of Use of Oral Anticoagulants and Vitamin K Antagonists in Patients with Intracerebral Hemorrhage. Jurnal Biologi Tropis, 22(4), 1245–1252. https://doi.org/10.29303/jbt.v22i4.4176

Most read articles by the same author(s)

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.